Resources

Since its creation in 2017, Hepatitis C: State of Medicaid Access has evaluated hepatitis C treatment policies across state Medicaid programs. In response to advocacy and litigation, many states have reduced or eliminated their restrictions, but significant barriers remain in a majority of jurisdictions. This webinar presents our latest snapshot of the national HCV treatment landscape and our team's insights into the road that lies ahead.

During the February 2024 Grassroots Advocacy Call, we chatted with Drs. Margaret Hayden and Sanjay Kishore of EJI Health about their work providing free health screenings and services (including hepatitis C and substance use care) to people released from jail or prison in Alabama.

Resources on using Section 1115 waivers to combat hepatitis C in jails and prisons

This Liver Awareness Month and American Pharmacists Month we hosted a fireside chat about pharmacists' role in viral hepatitis elimination, from prevention and testing to care and treatment.

National Viral Hepatitis Roundtable (NVHR) and NASTAD hosted a two-day virtual convening showcasing promising models and best practices for integrating hepatitis C testing and treatment into key settings.

NVHR and Hepatitis B Foundation hosted CDC's Division of Viral Hepatitis to discuss the new 2021 Viral Hepatitis Surveillance Report and the 2023 Viral Hepatitis National Progress Report.

During the June 2023 NVHR Grassroots Advocacy Call we discussed new Medicaid waiver opportunities for covering viral hepatitis and other reentry services in jails and prisons. Download Slides HERE For guidance on model policies for scaling up Hepatitis C virus (HCV) testing and treatment in United States prisons and jails, check out this white paper...

The May 2023 NVHR Grassroots Advocacy Call celebrated Hepatitis Testing Day by hearing from clinics and community-based organizations around the country who are leading innovative field and street-based viral hepatitis testing.

The National Viral Hepatitis Roundtable and Hepatitis B Foundation hosted the first-ever Quarterly Hepatitis Roundtable on March 16, 2023. This quarter, we hosted White House advisors Francis Collins and Rachael Fleurence to discuss a national hepatitis C elimination program.

Since its creation in 2017, Hepatitis C: State of Medicaid Access has evaluated hepatitis C treatment policies across state Medicaid programs. In response to advocacy and litigation, many states have reduced or eliminated their restrictions, but significant barriers remain in a majority of jurisdictions. This webinar presents our latest snapshot of the national HCV treatment landscape and our team's insights into the road that lies ahead.

During our January 2023 grassroots advocacy call we sat down with Nick Florko from STAT to discuss his investigation titled "Death Sentence" about the failure of state prisons to provide hepatitis C treatment. Read about the investigation here: https://www.statnews.com/death-sentence/

This webinar discusses clinical trial experience as it relates to access and equity. This webinar is part TWO of a two-part series intended for patients, advocates, and other stakeholders who are interested in learning more about the clinical trial process for HBV and HDV. The webinar is co-hosted by the Hepatitis B Foundation and the National Viral Hepatitis Roundtable (NVHR).

This webinar provides an overview of the clinical trial process, current HBV and HDV therapies, and an introduction to interpreting clinical trial data. This webinar is part ONE of a two-part series intended for patients, advocates, and other stakeholders who are interested in learning more about the clinical trial process for HBV and HDV. The webinar is co-hosted by the Hepatitis B Foundation and the National Viral Hepatitis Roundtable (NVHR).

Hepatitis D Patient Education & Support Hepatitis D Questions and Answers for the Public, Centers for Disease Control and PreventionQuestions and answers on hepatitis D transmission, risk factors, testing, signs and symptoms, and treatment. Hepatitis Delta Connect, Hepatitis B FoundationA dedicated program of the Hepatitis B Foundation to increase awareness about hepatitis delta, to promote...

Hepatitis C Patient Education & Support What is Hepatitis C?, Centers for Disease Control and PreventionAn overview of hepatitis C transmission, risk factors, testing, signs and symptoms, and treatment. Know More Hepatitis, Centers for Disease Control and PreventionA national communications campaign promoting hepatitis C testing. Campaign materials include posters, fact sheets, radio scripts, social media...

Hepatitis B Patient Education Hepatitis B Questions and Answers for the Public, Centers for Disease Control and PreventionAn overview of hepatitis B transmission, risk factors, testing, signs and symptoms, and treatment. Hepatitis B Patient Education Resources, Centers for Disease Control and PreventionSlide sets and printable fact sheets about hepatitis B, including materials for Asian Americans,...

Hepatitis A Patient Education Hepatitis A Outbreaks, Centers for Disease Control and PreventionAn overview of hepatitis A outbreaks, including bilingual (English/Spanish) resources for the public such as fact sheets, pocket cards, and posters on people who use drugs, gay and bisexual men, people experiencing homelessness, and people who have a history of incarceration. Hepatitis A...

Since its creation in 2017, Hepatitis C: State of Medicaid Access has evaluated hepatitis C treatment policies across state Medicaid programs based on three criteria: liver disease severity (“fibrosis”), alcohol and drug use (“sobriety”), and prescriber limitations. In response to advocacy and litigation, these restrictions have been reduced or eliminated in many states, increasing access to lifesaving treatment. Yet significant barriers remain. Hepatitis C: State of Medicaid Access considers new and existing barriers to treatment access and dives deeper into the role that state Medicaid programs play in progressing towards a country free of viral hepatitis.